Topamax is a medication that has been shown to significantly improve symptoms for individuals with epilepsy. Unfortunately, recent research has shown that mothers who take this medication while pregnant are at a significantly higher risk of having a child with a birth defect than those who were on other anticonvulsant medications or those not taking medications at all. These birth defects can have a remarkably negative impact on the lives of both the child and their parents.
Until recently, the impact of Topamax on pregnant women and their children was not widely known. However, the FDA has now placed Topamax in Category D for pregnant users, indicating that these effects are now acknowledged and that the use of Topamax may be inadvisable for pregnant women. For women who have already suffered the birth of a child with a birth defect, however, this stands as little consolation for the pain and suffering they’ve undergone.
Birth Defects Linked to Topamax
The use of Topamax has been primarily associated with the development of three different birth defects, which include the following:
- Cleft Lip
- Cleft Palate
Without treatment, some of these conditions have the potential to pose life-threatening health challenges to those who suffer them. Unfortunately, the treatment options available for families with children born with any of these conditions are often prohibitively expensive, placing families in the difficult position of choosing between their own financial stability and their children’s health. No family should have to cope with this type of terrible decision.
Fortunately, those whose children developed a birth defect as a result of the drug Topamax may be entitled to seek compensation for their losses through a Topamax lawsuit. Because its medication was more dangerous for pregnant women than initially acknowledged, the makers of Topamax may be held financially liable for the damages they may have caused.